Through analyzing the current situation of clinical comprehensive evaluation researches of domestic medical products from 2013 to 2023,it is found that there is a phenomenon of"four more,four less".Specifically,there is a greater emphasis on conducting research on drug clinical comprehensive evaluation,but fewer comprehen-sive evaluation opinions provided;more research data come from publicly available information,but fewer derived from real world;more options for similar reference drugs,but less pre-defined research on reference drugs;the re-search process involves more steps,yet there are fewer studies strictly implementing quality control.Based on this,suggestions are proposed in three aspects:improving the quality of clinical comprehensive evaluation of medical products,enhancing the transformation and dissemination of results,and improving the standardization of clinical comprehensive evaluation of medical products.Regarding the current state of clinical comprehensive evaluation re-search on Chinese patent medicine,reflections are presented on elevating original research evidence and highlighting the characteristics and advantages of Chinese patent medicine,so as to promote better transformation and application of the results of clinical comprehensive evaluation of medical products.
clinical comprehensive evaluation of medical productsChinese patent medicinewestern medicinemulti-criteria decision analysis
维普
万方数据
